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Abstract
Background:  The tryptophan catabolizing enzyme, indoleamine 2,3, dioxygenase (IDO) is one of
two mammalian enzymes, which can catabolize the rarest essential amino acid, tryptophan. IDO is
inducible by cytokines such as interferon-γ  and plays a role in inflammation and maternal tolerance
of fetal allografts, although its exact mode of action is unclear. Therefore, we investigated the
circumstances under which IDO is expressed in vitro together with the effects of overexpression
of IDO on the growth and morphology of cells.
Results:  Overexpression of IDO in the murine macrophage cell line RAW 264.7 and the murine
fibrosarcoma cell line MC57, resulted in the growth of macroscopic cell foci, with altered cell
adhesion properties. The expression of IDO was also detected during adhesion of wild type,
nontransfected  cells  in  tissue  culture  to  standard  cell  growth  substrates.  Inhibition  of  this
expression, likewise resulted in alterations in cell adhesion. Overexpression of IDO or inhibition
of endogenous IDO expression was accompanied by changes in metalloproteinase expression and
also in the expression and activity of the cyclooxygenase enzymes. In the case of RAW cells, IDO
effects on cell growth could be reversed by adding back prostaglandins.
Conclusions:  T he se  res ult s s ugges t that cat abolism of t he  rare st  es se nt ial amino acid  may
regulate processes such as cell adhesion and prostaglandin synthesis.
Background
Two known enzymes catabolize the essential amino acid
tryptophan in mammals. Tryptophan 2, 3 dioxygenase
(TDO) is expressed predominantly in hepatic tissues and
was the first inducible enzyme system discovered in
mammals [1]. It controls serum tryptophan homeostasis
and is induced following ingestion of tryptophan. A sec-
ond enzyme, IDO, is distinguished from TDO by its ex-
pression pattern, substrate specificity and inducibility.
IDO is expressed in a variety of non-hepatic tissues, in-
cluding placenta, lung, gut and epididymis [2,3,4]. Ex-
cept for the last named tissue where IDO is expressed
constitutively, IDO is inducible by inflammatory media-
tors, including interferons. In addition, IDO catalyzes
the breakdown of a variety of compounds which contain
an indole ring, including D-tryptophan and serotonin,
marking another difference from TDO, which is specific
for L-tryptophan. Curiously, it appears as if tryptophan
itself cannot induce IDO synthesis [5]. IDO is also sug-
gested to be the evolutionary ancestor of certain novel
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myoglobins which occur in molluscs, marking IDO as an
evolutionarily primitive enzyme [6].
IDO is known to be expressed in cells infected with intra-
cellular pathogens such as Toxoplasma and Chlamydia
species and also by viruses [7,8,9,10]. In the case of Tox-
oplasma and Chlamydia it has been proposed that IDO
induction is a cellular defense mechanism, designed to
limit the proliferation of the invading pathogen by de-
pleting the essential amino acid tryptophan. IDO ex-
pressed in monocyte derived macrophages has also been
found to inhibit the growth of extracellular bacteria such
as group B streptococci [11], and is also induced in tu-
mors taken from cancer patients [12]. In all of these sys-
tems the proximal inducer of IDO activity is interferon-γ
(IFN-γ ). Response elements for this cytokine have been
identified in the human IDO promoter and have been
shown to be essential for IFN-γ  induction of reporter
gene expression in vitro [13,14,15].
The unusual tissue distribution of IDO suggests that
combating infection is not its only function. Our interest
in IDO arose when we observed that tryptophan deple-
tion was responsible for macrophage-induced inhibition
of T cell proliferation in vitro [16]. Furthermore, we re-
ported that a pharmacologic inhibitor of IDO, 1-methyl
tryptophan, induced maternal rejection of allogeneic but
not syngeneic murine fetuses [17]. As IDO is strongly ex-
pressed at the maternal-fetal interface in pregnant mice
and women, we have suggested that IDO plays a role in
fetal defense against the maternal immune system and
could represent a novel means of immunoregulation.
The apparently diverse functions and tissue distribution
of IDO may have as a common theme the fact that tryp-
tophan is the rarest essential amino acid and could be the
target for cellular regulatory mechanisms. If so, tryp-
tophan concentrations in cellular microenvironments
might play a critical role in modulating various cellular
processes in a way that cannot be achieved by the hepatic
enzyme TDO which regulates systemic tryptophan con-
centrations.
The IDO promoter contains a diverse collection of motifs
together with the IFN-γ  response elements. These in-
clude motifs for transcription factors that bind to colla-
genase and elastase genes and motifs for the
transcription factor MEP-1, which regulates transcrip-
tion from the stromelysin-1 (MMP-3) and metal-
lothionein genes [18,19]. Matrix metalloproteinases
(MMPs) are responsible for modification of the extracel-
lular matrix and are involved in wound healing, tumori-
genesis, pregnancy and inflammation. In general, they
regulate how cells interact with each other and with the
extra-cellular matrix. Evidence for a tryptophan-reversi-
ble inhibition of MMP expression by IFN-γ  has previous-
ly been presented [20, 21], although the exact
mechanism is unclear. Therefore we decided to directly
test whether IDO plays a role in controlling interactions
with other cells and also the surrounding extracellular
environment.
We have identified cells expressing IDO in vitro and used
IDO antisense constructs to inhibit this expression. In
addition, we have constitutively overexpressed IDO in
adherent and non-adherent cell lines in vitro. Our re-
sults demonstrate that tryptophan catabolism has signif-
icant effects on cell adhesion and regulates the activity
and expression of cyclooxygenases 1 and 2 (COX-1 and -
2).
Results
Constitutive overexpression of IDO alters cell adhesion
To determine whether IDO plays a role in regulating cell
adhesion, we expressed a full-length IDO cDNA in cell
lines in vitro. We transfected the murine macrophage
cell line RAW 264.7 with a construct in which IDO was
expressed under the control of the murine MHC Class II
promoter (Fig 1A). IDO-transfected RAW cell clones,
which expressed IDO under the control of the MHC Class
II promoter, were characterized for IDO expression. We
selected four clones with varying capacities for IDO ex-
pression and tryptophan depletion from culture medium
(Fig 1B,C,D,E). Following 48 hours in culture, clones 22
and 11 depleted tryptophan to a greater extent than
clones 6 and 8 or vector only control, consistent with the
greater vector copy number of these clones. However,
none of the clones depleted a substantial proportion of
the tryptophan present in medium even with longer in-
cubation times. A common feature of the tryptophan de-
pleting clones was their tendency to form macroscopic
foci, which were visible to the naked eye (Fig 2,A,B,C). At
a certain point in focus growth, multicellular aggregates
of RAW cells would break off from the focus and could be
seen floating in suspension in the tissue culture medium.
Wild type RAW cells or RAW cells transfected with vec-
tor alone and, to a lesser extent, clones 6 and 8 demon-
strated a reduced ability to form macroscopic foci.
To determine if this phenomenon was unique to RAW
cells, we also transfected the MC57 murine fibrosarcoma
cell line [22] which grows as a monolayer. MC 57 cells are
fibroblastic in appearance and disperse across the sur-
face of a tissue culture dish in a uniform manner. Trans-
fection of a full length, constitutively expressed IDO
cDNA into MC57 cells in the pcDNA3 expression vector,
resulted in MC57 cells developing a more rounded phe-
notype. Furthermore, cells grew as multicellular foci, in
a confined area, similar to RAW cells, although the foci
did not grow to as large a size before detaching from the
plate (Fig 2D,E). The murine monocytic cell line P388BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
was also transfected and expressed IDO. It likewise ex-
hibited a change in morphology similar to that described
above and clones expressing IDO often changed from
non-attached suspension cultures to adherent cultures
which resembled RAW cells(not shown).
IDO-expressing clones were also slower to re-attach to
tissue culture dishes following sub-culture and could be
seen floating as multicellular aggregates. To quantitate
the change in cell adhesion in IDO-transfected RAW
cells, we performed binding studies to tissue culture
plates coated with various extra-cellular matrices, in-
cluding collagen, laminin, matrigel, and fibronectin. Nei-
ther vector-only controls nor IDO-expressing cells
adhered significantly to laminin or matrigel coated
plates in a 45 minute assay period (not shown) and both
controls and IDO-expressing cells adhered strongly and
to similar extents to fibronectin coated plates (Fig 3A).
Figure 1
Characterization of RAW cell transfectants. (A) IDO construct used to transfect RAW cells showing X, Y and W/S
boxes of MHC Class II promoter. (B) Relative copy number determination of IDO-transfected RAW cell clones. The rabbit β
globin intron present in the construct was used as a probe for hybridization by slot blot. (C) RT-PCR of total RNA isolated
from RAW transfectants following 15 cycles of RT-PCR, electrophoresis on 0.8% agarose, followed by Southern blotting and
hybridization with an IDO specific probe. (D) Western blot of IDO-expressing RAW cell transfectants, using IDO-specific pol-
yclonal antibody. (E) HPLC determination of tryptophan depletion from tissue culture medium by IDO-expressing RAW cells,
48 hours post-seeding into fresh medium. V; Vector-only control transfectant. Clones 6, 8, 11, 22; IDO-expressing RAW
clones.BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
However, there was a substantial difference in adhesion
to collagen-coated plates. Although neither sample ad-
hered to collagen to the same extent as to fibronectin,
vector only controls adhered more strongly than IDO-ex-
pressing clone 11 (Fig 3B).
IDO expression is induced during cell attachment to 
growth substrates
To determine if IDO normally plays a role during the
course of cell adhesion, we detached log phase, wild type
RAW cells from their culture flasks by scraping, reseeded
Figure 2
Phenotype of IDO-expressing transfectants. (A) Flasks of RAW cell clones stained with trypan blue and photographed
under normal light. Flasks are arranged in order of increasing IDO expression and show foci visible to the naked eye. V; Vector
only control. (B) Vector-only transfected RAW cells. (C) Clone 11 IDO-expressing RAW cells. (D) Vector-only transfected
MC57 cells. (E) IDO-expressing MC57 cell clone. Bar = 250 µ m.BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
them into fresh medium and assayed for IDO expression
at subsequent time points. Log phase cells do not express
IDO at levels detectable by standard RT-PCR methods.
However, in cells detached from their normal growth
substrate, IDO expression was already induced by 5
hours following reseeding into fresh tissue culture dishes
and expression was detected until 48 hours (Fig 4A). On-
set of expression coincided with the time when the ma-
jority of cells had begun to adhere to the plate.
To determine if IDO expression was restricted to cell in-
teractions with standard tissue culture substrates and to
further explore the possibility that IDO altered inter-cel-
lular adhesiveness, we studied the murine embryonic
carcinoma cell line P19. This cell has been characterized
extensively and differentiates into skeletal and cardiac
muscle or neuronal cells, depending on whether it is
treated with DMSO or retinoic acid (RA) respectively
[23, 24, 25]. Differentiation is dependent on an initial, 3-
5 day incubation as multicellular aggregates in suspen-
sion culture, in the presence of drug, followed by a simi-
lar period growing as monolayer adherent cells in the
absence of drug. Mature differentiated cells begin to ap-
pear during this subsequent growth period in the ab-
sence of drug.
IDO expression was detected when P19 cells were re-
seeded into bacterial petri dishes as suspension cultures
and allowed to form aggregates. IDO expression was ob-
served within 12 hours of seeding into suspension with
DMSO and peaked around 48-54 hours. (Fig 4B). Thus,
removing cells from their normal growth substrate and
reseeding into fresh medium induced a burst of IDO ex-
pression irrespective of whether cells reassociated with
tissue culture substrate or other cells. Aggregating cells
in the presence of 10-6 M RA, which induces neuronal
differentiation also induced a transient burst of IDO
transcription but the period was shorter and the peak
level observed was lower than that observed with DMSO.
To determine if IDO expression was related to the re-
moval of cells from their normal growth substrate or the
process of reattachment to new substrate, we trypsinized
P19 cells and reseeded them as aggregates in suspension
in the presence of various concentrations of EGTA.
EGTA chelates essential Ca2+ required by cadherin mol-
ecules and inhibits cell adhesion. We observed a concen-
tration dependent decrease in IDO expression in EGTA
treated samples 24 hours after seeding, which paralleled
a corresponding decrease in cell aggregation (Fig 4C).
Therefore, IDO expression appeared to be induced by
reattachment, rather than detachment from a previous
substrate. Thus, IDO is thus expressed endogenously in
various cell types and is induced during cell attachment
to growth substrates.
Inhibition of endogenous IDO expression disrupts P19 cell 
adhesion
To examine the role of IDO expression in P19 cells, we
transfected P19 cells with a DNA construct which con-
tained a 740 bp fragment of murine IDO cDNA in the an-
tisense orientation, under the control of the
constitutively active CMV promoter in the pcDNA-3
mammalian expression vector. As control, the IDO gene
fragment was cloned in a sense orientation. To confirm
that transfected, G418 resistant P19 cells expressed IDO
antisense transcripts, we isolated total RNA from G418
resistant clones, reverse transcribed it into cDNA using a
sense primer then PCR amplified the cDNA. Three anti-
sense-transfected clones, which expressed progressively
greater amounts of IDO antisense RNA were selected for
further analysis together with a sense control (Fig 4D).
The ability of the sense and antisense transfectants to de-
plete tryptophan from culture medium was determined
following 48 hours in culture. IDO sense transfected P19
cells depleted 10% of available culture tryptophan (not
shown) while IDO antisense transfected P19 clones
which expressed high levels of antisense (clones D3 and
E6) depleted essentially no tryptophan from the medi-
um. Clone C2, which expressed low levels of IDO anti-
sense, depleted similar levels of tryptophan to the sense
control. Therefore, the burst of IDO expression, which
takes place in cells during reattachment does not result
in substantial tryptophan depletion from culture medi-
um
Figure 3
Adhesion  properties  of  IDO-expressing  RAW  cell
transfectants. (A) Adhesion of clone 11 and vector-only
RAW cells to fibronectin coated tissue culture dishes. 5 ×
105 RAW cells were seeded into 24 well tissue culture plates
coated with fibronectin and the percentage of cells adhering
to the plate 45 minutes later was determined. (B) Adhesion
of clone 11 and vector-only RAW cells to type I collagen-
coated tissue culture dishes. Assay system was the same as
for A.BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
IDO antisense-transfected clones D3 and E6 exhibited a
different phenotype compared to untransfected and
sense transfected P19 cells (Fig 5A,B,C). IDO antisense
expressing clones developed a rounded appearance with
a more scattered morphology and apparent loss of cell
interaction instead of the usual, adherent P19 pheno-
type. The degree to which this phenotype manifested,
correlated with the extent of IDO antisense expression,
i.e. it was prominent in clone E6 and D3 while clone C2
was indistinguishable from sense-transfected controls.
However growth rates were largely unaltered. IDO-anti-
sense and sense transfectants were aggregated in 1%
DMSO and cell aggregates were visualized by phase con-
trast microscopy. Sense or untransfected P19 cells aggre-
gated normally as tightly packed spheroid bodies. In
contrast, antisense transfectants formed aggregates,
which exhibited markedly different morphologies and
differed from sense-transfected aggregates in two princi-
pal respects; shape and size (Fig 5D,E,F). At 30 hours af-
ter seeding suspension cultures, cells formed irregular
shaped, non-spherical aggregates that were less tightly
packed than control aggregates. Antisense clone E6
(shown in Fig. 5F) produced aggregates which were only
loosely packed and a substantial number of cells which
did not package into any form of aggregate while anti-
sense clone D3 formed aggregates more diverse in shape
than the uniformly spherical controls but less diverse
than clone E6. Clone C2 produced aggregates similar to
sense transfected controls (not shown).
To quantitate and compare the size difference between
sense and antisense-transfected aggregates we photo-
graphed sense and antisense clone 5 aggregates and cal-
culated the area of each aggregate individually (Fig. 5G).
Antisense aggregates were small, predominantly in the
0.2-0.4 sq. inch size range, whereas control aggregate
sizes were spread over a much broader range. The mean
size of antisense-transfected aggregates was 0.31 sq.
inches, while sense transfected controls had a mean of
0.69 sq. inches (p < 0.0001). The effect of IDO inhibition
on cell adhesion was demonstrated by performing cell
migration assays. P19 cells were seeded into porous tis-
sue culture inserts placed in a 24 well tissue culture plate
and cell migration to the lower chamber in the absence of
Figure 4
IDO expression in RAW and P19 cells in vitro. (A) RAW cells were harvested by scraping and 1 ×  106 cells were seeded
into 5 ml culture dishes. Cultures were harvested at various time points and assayed for IDO expression by RT-PCR. (B) P19
cells were aggregated in suspension cultures in the presence of either 1% DMSO or 10-6 M RA. Cultures were harvested at
various time points and assayed for IDO expression by RT-PCR. (C) Effect of EGTA on expression of IDO 24 hours following
seeding of P19 aggregates. P19 cells were seeded into suspension cultures in the presence of 5 mM (lane 1), 3 mM(lane 2), 1
mM (lane 3) or no EGTA (lane 4). (D) IDO antisense expression. RT-PCR products electrophoresed on 0.8% agarose. Lanes;
1&2: antisense clone C2, 3&4: antisense clone D3, 5&6: antisense clone E6, 7: molecular weight marker. Lanes marked with +
or -; reverse transcriptase present or absent respectively.BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
any stimulus was determined. Approximately 12% of
clone E6 cells migrated to the lower chamber 18 hours af-
ter seeding into the upper chamber (Fig. 5H). In con-
trast, less than1% of control cells had migrated in the
same period. Clones C2 and D3 produced intermediate
levels of migration. When inserts were coated with
Matrigel, no significant migration was seen in either an-
tisense or sense transfectants, indicating that cell motili-
ty could be inhibited by supplying an extracellular
matrix.
IDO axpression alters metalloproteinase expression
The altered adhesion of IDO-expressing RAW cells to
collagen suggested that IDO might induce alterations in
enzymes involved in modifying the extracellular matrix.
Therefore, we investigated whether inhibition of IDO ex-
pression in the P19 in vitro aggregation system and the
constitutive overexpression of IDO in RAW cells had any
effect on MMP expression. We allowed the sense and
three-antisense expressing clones of P19 to aggregate in
1%. DMSO for 24 hours, before harvesting total RNA and
determining expression of various MMP genes, includ-
ing stromelysins 1 (MMP-3), 2 (MMP-10) and 3 (MMP-
Figure 5
Phenotype of IDO-antisense transfected P19 cells. (A-C) P19 cells growing as a monolayer. (A) IDO-sense (B) IDO-
antisense transfected P19 clone D3 (C) IDO antisense clone E6, growing as a monolayer. Bar:1 mm. (D-E); P19 cells growing as
aggregates. (D) Aggregates from IDO sense-transfected P19 cells, (E) aggregates from IDO antisense-transfected P19 clone D3
grown in suspension for 30 hours in the presence of 1% DMSO. (F) Clone E6 treated as for D3. Bar: 50 mm (G) A represent-
ative field at 10x magnification was selected and the areas of 50 individual aggregates was calculated for both sense and anti-
sense clone E6. Results are shown as the percentage of the total aggregates analyzed whose areas are within a given 0,2 sq. inch
interval. (H) Percentage of IDO-sense and-antisense transfected P19 cells migrating to lower chamber of 24 well tissue culture
plates18 hours following seeding. S: sense control, E6, D3, C2: antisense clones.BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
11), collagenases I (MMP-1) and IV (MMP-2) and melt-
rins α  (ADAM-12) and β  (ADAM-19). Meltrin α  is ex-
pressed in vivo during development in condensed
mesenchymal cells that give rise to skeletal muscle while
meltrin β  is expressed in craniofacial and dorsal root
ganglia where neuronal lineages differentiate [26]. Ex-
pression of stromelysins-1 and 3 and meltrin α , was in-
creased in antisense-expressing aggregates, relative to
the sense control (Fig 6A). Furthermore, there was a pro-
gressive increase in the expression level of these three
protease genes, which correlated with the amount of IDO
antisense expression. In contrast, the expression of melt-
rin-β  and stromelysin-2 was similar in all samples and
expression of collagenase I or IV was undetectable in ei-
ther sense or antisense-expressing aggregates (not
shown). Thus, inhibition of IDO gene expression corre-
lated with increased expression of some but not all MMP
genes in P19 cells undergoing aggregation. Furthermore,
increased MMP expression coincided with decreased
ability of P19 cells to aggregate in suspension culture. To
determine whether IDO-expressing RAW cells also
showed unusual MMP expression we tested the IDO-ex-
pressing RAW cell clones for the same group of MMPs as
P19 cells. Expression of all MMPs was undetectable ex-
cept for collagenase I. This showed significant expres-
sion in vector-only controls but little or no expression in
IDO-expressing clones. All IDO-expressing clones dem-
onstrated reduced expression with no correlation to the
level of IDO expression (Fig 6B). Pharmacological inhi-
bition of MMP activity in P19 cells using the broad spec-
trum, hydroxamic acid-based MMP inhibitor GM 6001
at concentrations ranging from 1-30 µ M, resulted in par-
tial reversal of the poor aggregation shown by IDO-AS
expressing cells, with a maximal effect shown at 20 µ M,
indicating that changes in MMP expression were respon-
sible, at least in part for altered cell adhesion.
IDO regulates prostaglandin synthesis
To understand the mechanism of IDO induced altera-
tions in cell adhesion and MMP expression, we attempt-
ed to reverse IDO effects on cell adhesion. As previously
mentioned, tryptophan is not significantly depleted in
culture medium of RAW cells overexpressing IDO, sug-
gesting that tryptophan deprivation is not the cause of
the IDO effect. Consistent with this, adding back tryp-
tophan to IDO-expressing RAW cells did not reverse the
growth of macroscopic foci. As tryptophan is not the only
substrate for IDO, we also investigated whether adding
serotonin would overcome the effects of IDO expression.
There was a similar lack of effect of this compound. This
suggested that depletion or reduction of an IDO sub-
strate was probably not responsible for the effects de-
scribed here. An alternative possibility was that a
biologically active downstream catabolite of IDO could
be the cause. Therefore, we tested the tryptophan catabo-
lites, picolinic acid and quinolinic acid to see if they could
reproduce the effects of IDO overexpression. Picolinic
acid (1-6 mM) produced morphological changes in both
MC57 and RAW cells and also substantial reductions in
growth rate but did not mimic the effects of IDO expres-
sion. In particular, at a concentration of 2 mM, picolinic
acid induced a more flattened phenotype. At concentra-
tions above 6 mM, picolinic acid-induced apoptosis was
observed. Quinolinic acid was essentially without effect
at concentrations up to 10 mM. Therefore, the exact
mode of action of IDO therefore remains to be deter-
mined.
Despite the uncertainty about the proximal mediator of
IDO's effect, it is known that alterations in cell adhesion
and metalloproteinase activity are often associated with
changes in prostaglandin synthesis [27,28,29,30].
Therefore, we analyzed the spectrum of PGs produced by
IDO-expressing RAW cells using thin layer chromatog-
raphy. PG D2 was the major product of both vector-only
controls and IDO-expressing clone 11, consistent with re-
ports that D2 production is typical of antigen-presenting
cells [31]. There was a greater than 50% reduction in PG
D2 production in clone 11 compared with the vector only
control and a similar decrease in levels of PGs F2α , 6keto-
F1α  and thromboxane B2 in this clone (Fig 7A). However,
PG E2 production was affected relatively little compared
to the other PGs. Thus IDO overexpression resulted in an
increase in PG E2 relative to the other PGs. However, in
MC57 cells, the prostaglandin profile was quite different
from that seen in RAW cells. PG E2 was the dominant
prostaglandin (Fig 7B) and overexpression of IDO result-
ed in a relative increase in the amount of PG D2 and other
PGs, relative to E2.
In IDO-expressing RAW cells, COX-1 protein levels were
unchanged compared to the vector-only control (Fig 8A).
In contrast, COX-2 was not expressed by vector only con-
trols or RAW clones 6, 8 and 22 but COX-2 mRNA and
protein was induced in the RAW clone expressing the
greatest amount of IDO (clone 11) (Fig 8A). Although
COX-2 is not usually expressed in RAW cells, it can be
strongly induced with lipopolysaccharide (LPS) [32, 33].
Therefore, we treated IDO transfected RAW cells and
controls with LPS and measured COX-2 expression 24
hours later. COX-2 mRNA was most strongly induced in
vector only or low IDO-expressing clones (Fig 8B). Curi-
ously, clones expressing higher levels of IDO (clones 22
and 11) showed lower levels of COX-2 mRNA induction.
In contrast, COX-2 protein levels were higher in clones
expressing lower amounts of IDO mRNA and lower in
vector only controls, whereas COX-1 protein levels were
unchanged by LPS treatment. MC57 cells expressed
COX-2 constitutively, consistent with the domination of
the PG profile by PG E2. However, IDO overexpressingBMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
clone 26 showed a reduced amount of COX-2 protein
compared to the vector only control (Fig 8C).
If uniformly diminished PG synthesis by IDO was re-
sponsible for growth of RAW cell macroscopic foci, in-
hibiting PG synthesis with a pharmacological inhibitor of
COX-1 and -2 ought to reproduce the effect of IDO ex-
pression. Therefore we treated vector-only transfected
RAW cells with various concentrations of indomethacin
ranging from 0.1 µ M to 100 mM. Although some effect of
indomethacin on cell growth rate was observed, there
was no sign of macroscopic foci (data not shown). Thus
IDO expression does not mimic the effects of a global
COX inhibitor. To test the hypothesis that alterations in
the relative levels of PGs were responsible for the growth
of macroscopic foci, we added PGs directly to vector-only
transfected RAW cells. The phenotype produced by IDO
expression could be reproduced by adding PG E2 alone to
the cultures. PG E2 addition resulted in a dose-depend-
ent increase in the appearance of macroscopic foci, with
visible foci appearing at 1 ng/ml (3 nM) and becoming
abundant at 10 ng/ml (30 nM) (Fig. 9A). Adding PG F2α
at the same time as E2 resulted in a reduction of the
number of foci. Surprisingly, addition of PG D2 also re-
sulted in a slight increase in focus numbers (not shown).
We next attempted to reverse the phenotype seen in
clone 11 cells. If increased PG E2 production relative to
other PGs was responsible for the appearance of macro-
scopic foci, then adding back increasing amounts of oth-
er PGs such as D2 and F2α  should restore the phenotype
of clone 11 to that of vector only controls. As PG F2α  at-
tenuated the focus forming ability of PG E2 in the exper-
iment shown in Fig. 9A, we added PG F2α  in various
concentrations to clone 11 cells. PG F2α  at 10 ng/ml (30
nM) substantially reduced the focus forming ability of
IDO expressing clone 11 (Fig 9B). Thus an alteration in
the PG E2/F2α  ratio plays an important role in mediating
IDO's effects on cell growth and morphology.
Discussion
Tryptophan catabolism by cells expressing IDO is some-
thing of an enigma and has resulted in speculation as to
why the body requires two enzymes with different tissue
specificities to degrade the rarest essential amino acid [5,
34]. The inability of IDO to be induced by its own sub-
strate exemplifies this puzzle. While IDO's role in con-
trolling intracellular pathogens is well documented,
there is little understanding of the reasons for IDO ex-
pression at sites in the body unlikely to be related to this
function, such as the epididymis. The data we present
here reveal that IDO expression is an important determi-
nant of the way in which cells interact with their extracel-
lular environment in vitro. In particular, cell adhesion is
altered dramatically by overexpressing IDO in cells
which do not otherwise express it, or inhibiting IDO ex-
pression in cells in which it is naturally induced following
cell passage. Specifically, overexpression of IDO in RAW
and MC57 cells resulted in the growth of macroscopic
foci and other phenotypic alterations. The cell foci were
multicellular aggregates, which grew vertically as well as
horizontally across the plate surface and contained sig-
nificant numbers of necrotic cells within their interior, as
judged by trypan blue exclusion. Conversely, in P19 cell
aggregates in which IDO expression was inhibited, there
was a more dispersed phenotype with cells losing the
ability to interact with each other. We have recently con-
firmed that IDO expression in RAW cells following cell
passage is likewise important for correct cell adhesion
(results not shown).
Our data support the hypothesis that IDO-induced alter-
ations in PG synthesis can modify cell adhesion. We ob-
served changes in the relative amounts of PGs in IDO-
Figure 6
Effect of IDO  on  metalloproteinase  expression. ( A )
IDO sense and antisense-transfected P19 cells were aggre-
gated in 1% DMSO for 30 hours before total RNA was iso-
lated and metalloproteinase gene expression assayed by RT-
PCR. Lanes: 1-antisense clone E6, 2-antisense clone D3, 3-
antisense clone C2, 4-sense. (B) Collagenase gene expression
in IDO-e xpre ssing R AW transfec tants. V:  ve ct or-only , 6,8,
11, 22: IDO expressing RAW clones.BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
Figure 7
Effect of IDO expression on prostaglandin production. (A) Analysis of prostaglandin production by vector-only trans-
fected RAW cells () and IDO-expressing clone 11 () (B) Analysis of prostaglandin production by vector-only transfected () and
clone 24 () IDO-expressing MC57 cells.BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
transfected RAW cells and reversal of the effects of IDO-
expression by PG F2α  while PG E2 stimulated focus for-
mation. COX-2 was upregulated in IDO-expressing RAW
cells. Similar effects of PG E2 on cell morphology have re-
cently been reported in the human embryonic kidney cell
line HEK 293, which overexpressed COX-2 and PG E2
synthase [35]. COX-2/PG E2 synthase-expressing cells
were highly aggregated, piled up and exhibited round
shape morphology similar to the RAW cells described
here. MC57 cells, which demonstrated similar changes in
cell adhesion to RAW cells following IDO expression, ex-
hibited lower levels of COX-2 synthesis upon IDO ex-
pression and lower levels of PG E2 relative to other PGs
such as D2. Furthermore, adding back PGE2 to IDO-ex-
pressing MC57 cells did not reproduce the wild type phe-
notype (not shown). Thus, similar effects on cell
morphology were produced by opposite effects on COX-
2 expression and PG E2 production in these two cell
lines. We are presently attempting to determine if prod-
ucts of COX-2 activity other than E2 may be responsible
for IDO effects in this cell line.
The mechanism of PG-induced changes in cell adhesion
and morphology may involve MMP activity. Synthesis of
MMPs such as collagenase I (MMP-1), gelatinase B
(MMP-9) and matrilysin (MMP-7) has been shown to be
dependent on the synthesis of PG E2, suggesting that al-
terations in MMP expression may be instigated by alter-
ations in PG synthesis [27,28,29,30]. Furthermore, both
COX-1 and COX-2 have recently been shown to mediate
adhesion of various cell types in vivo and in vitro [36,
37]. Thus, one possibility is that alterations in MMP ex-
pression and activity could modify cellular interactions
with the extracellular matrix following IDO expression.
Consistent with this possibility is the observation that
MMP expression in P19 cells was correlated with the de-
gree of IDO-antisense expression. RAW transfectants
over-expressing IDO showed reduced expression of col-
lagenase I (MMP-1), and also bound less well to collagen-
coated plates than controls. Collagen is one of the princi-
pal components of the extracellular matrix and RAW
cells bind poorly to fibrillar type I collagen unless it is de-
natured or activated by collagenase [38]. Thus, the di-
minished expression of MMP-1 in IDO transfectants
could explain their weaker binding to this substrate. The
mechanism by which IDO regulates prostaglandin syn-
thesis is yet to be determined. Tryptophan is a stimulato-
ry co-factor for COX and degradation of tryptophan in
the intracellular environment could alter COX activity.
Alternatively, IDO might influence COX activity and ex-
pression through competition for or release of heme,
which both enzymes require. In vitro, arachidonic acid
stimulates the dissociation of heme from IDO and this
correlates with IDO stimulatory effects on COX [39],
providing circumstantial support for the latter possibili-
ty.
The alterations in COX-2 expression observed in IDO-
expressing RAW and MC57 cells are a particularly inter-
esting feature of our results. COX-2 is inducible by a
number of inflammatory mediators including IFN-γ  [40]
and LPS [32]. These also induce IDO. Treatment of IDO-
Figure 8
Effect of IDO on cyclooxygenase expression clones. (A) Expression of COX-1 and COX-2 protein by vector-only trans-
fected (Vo) and IDO expressing clones. (B) Effect of LPS treatment on expression of COX-1 and COX-2 in IDO-expressing
clones. Vector-only and IDO-expressing RAW cells were treated with 1 ng/ml LPS for 12 hours. (C) COX-2 expression in vec-
tor-only or IDO-expressing MC57 cells.BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
expressing RAW clones with a known inducer of COX-2
(LPS), revealed a lack of correlation between COX-2
RNA and protein levels. Clones 11 and 22 showed low
levels of COX-2 message but high levels of protein fol-
lowing LPS treatment. This suggests that COX-2 RNA
and/or protein turnover may be affected by IDO expres-
sion. Other workers have noted that non-steroidal anti-
inflammatory drugs, which inhibit COX activity result in
increased COX protein expression [41], while differences
between COX protein expression and activity have been
reported to be produced by some cytokines, including tu-
mor necrosis factor-α , and also nitric oxide donors [42,
43]. Although not well understood, evidence for regula-
tion of COX expression at the post-transcriptional level
is increasing [44, 45]. The down regulation of COX-2
transcripts in LPS-treated, IDO-expressing RAW cells is
reminiscent of the endotoxin tolerance effect observed in
human THP-1 promonocytic cells. Cells pretreated with
LPS and thus expressing COX-2 showed down regulation
of COX-2 mRNA when subjected to a second LPS expo-
sure [46]. In addition, the COX-2 inhibitor flufenamic
acid induced COX-2 expression in RAW cells but inhibit-
ed TNF-α  or LPS-induced COX-2 expression in the same
cell type [47].
As both MMPs and COX-2 are important factors in tu-
mor development [48, 49] IDO's role in tumorigenesis
bears investigating. We have observed IDO expression
routinely in murine tumors in vivo, and are presently in-
vestigating the growth properties of tumors with altered
IDO expression. In addition, our recent work indicates a
role for IDO during pregnancy. Pharmacological inhibi-
tion of IDO results in pronounced inflammation, com-
plement activation and fetal loss [17, 50]. Prostaglandins
may provide a common link between these important bi-
ological phenomena.
Conclusions
IDO regulates adhesion of cells to normal growth sub-
strates. In so doing it modulates the expression and ac-
tivity of COX-2 and certain MMPs. RAW cells and MC57
cells overexpressing IDO grew as multicellular foci. In
the case of RAW cells, this was due to elevated PGE rela-
tive to other prostaglandins. P19 cells in which endog-
enousIDO expression was disrupted by antisense
expression, showed lower adhesiveness. Thus, tryp-
tophan catabolism exerts control over fundamental cel-
lular functions.
Materials and Methods
Cells
P19 cells were obtained from the American Type Culture
Collection and cultured as described [23]. Cells were dif-
ferentiated into myocytes or neurones using 1% DMSO
and 10-6 M RA respectively as previously reported [23,
24]. RAW 264.7 cells were a gift of Dr. D. Greaves (Ox-
ford, England) and were cultured in Iscove's Modified
Dulbecco's Medium supplemented with 10% fetal calf se-
rum. MC57 cells were obtained from Dr. Dimitrios
Moskiphidis, Medical College of Georgia and grown in
Iscove's Modified Dulbecco's Medium.
IDO expression
A full length, 1.2 kb IDO cDNA was amplified from IFN-
γ  stimulated RAW cells and cloned into pGEM T-Easy
(Promega), using primers; 5' TAG CGG CCG CGT AGA
CAG CAA TGG CAC TC 3' forward, 5' TAA GAT CTT ACA
CTA AGG CCA ACT CAG 3' reverse, which contain Not I
and Bgl II sites respectively. The 1.2 kb IDO PCR frag-
ment was excised with Not I and Bgl II and cloned into
the Not I-Bgl II site in the pDOI vector [51], previously
modified by the introduction of a Not I site in front of the
Eco RI cloning site. Plasmid DNA was linearized and
transfected into RAW cells by electroporation. Stably
transfected lines were selected in 400 mg/ml G418 and
thereafter maintained in 200 mg/ml G418. MC57 cells
were also transfected by electroporation and selected in
1.2 mg/ml G418.
RT-PCR
Analysis of gene expression in P19 or RAW cells was per-
formed using semi-quantitative RT-PCR. Total RNA was
isolated from cells using RNA STAT-60 (Tel-Test Inc.)
Figure 9
Effect of exogenously added PGs on the growth of
RAW cells. (A) Vector-only transfected RAW cells were
incubated with the indicated concentrations of PGs for 48
hours and stained with trypan blue. (B) Clone 11 RAW cells
were incubated with the indicated concentrations of PGs for
48 hours and stained as for A.BMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
and 1 mg was amplified for 25 cycles unless otherwise
stated, following reverse transcription in a one step reac-
tion (RT-PCR "Access", Promega). 5 µ l of the 50 ml reac-
tion volume was electrophoresed on 0.8% agarose gels
prior to Southern blotting and hybridization with a spe-
cific probe. Primers and amplification conditions for
IDO amplification have been described elsewhere [17].
Primers for amplification of other gene specific tran-
scripts were as follows; stromelysin-1; 5' GATGACAG-
GGAAGCTGGA forward, 5' ACTGCGAAGATCCACTGA
reverse. Stromelysin-2; 5' GATGTACCCAGTCTACAGGT
3' forward, 5' TGTCTTGTCTCATCATTACT 3' reverse.
Stromelysin-3; 5' CTGCTGCTCCTGTTGCTGCT 3' for-
ward, 5' ACCTTGGAAGAACCAAATC 3' reverse. Meltrin-
α ; 5' TGCATCAGTGGTCAGCCTCA 3' forward, 5' CTT-
TCTCTGCGGCCATTCTG 3' reverse. Meltrin-β ; 5'
TTCAGTTTACACATCAGAC 3' forward, 5' AGGTCA-
CATTGCCGAACCT 3' reverse. Collagenase I; 5' GATT-
GTGAACTATACTCCT 3' forward, 5'
CCATAGTCTGGTTAACATCA 3' reverse. Collagenase IV;
5' GTATGGAGCGACGTCACT 3' forward, 5' CGCTCCA-
GAGTGCTGGCA 3' reverse. GAPDH; 5' TGCAGT-
GGCAAAGTGGAG 3' forward 5'
CCATCCACAGTCTTCTG 3' reverse.
Antisense inhibition of IDO expression
Constructs which expressed either sense or antisense
IDO RNA were produced by cloning a 740 bp RT-PCR
fragment of the IDO gene, described in [17], into the T-
tailed cloning vector pGEM T-Easy (Promega). This frag-
ment was excised with Not I and subcloned into the Not
I site of the mammalian expression vector pcDNA3 (Inv-
itrogen), in either the sense or antisense orientation. Fol-
lowing linearization with Bgl II, the constructs were
transfected into the P19 cell line using Lipofectamine
(Gibco-BRL) at a concentration of 25 µ l per 100 ml of se-
rum free medium. Stable transfectants were selected in
400 mg/ml G418 over a period of 4 weeks and subse-
quently maintained in the absence of G418 in normal
growth medium. Periodic checks of G418 resistance re-
vealed no significant loss of the resistance phenotype.
Confirmation that resisitant clones expressed IDO anti-
sense RNA was obtained by isolating total RNA from
G418 resistant clones, treating with ribonuclease free
DNase RQ1 (Promega) and reverse transcribing RNA
into cDNA in the presence of an IDO sense primer [17].
An antisense primer was then added and the cDNA PCR
amplified for 25 cycles. Products were electrophoresed in
0.8% agarose.
Western blotting
RAW cells expressing IDO and vector only controls were
harvested in cell lysis buffer (PBS, 1%NP40, 0.5% sodi-
um deoxycholate, 0.1% SDS, 150 ng/ml PMSF, 100 ng/
ml aprotinin) and 25 µ g of cell protein was electro-
phoresed on 10% polyacrylamide gels overlayed with a
5% stacking gel. Protein was quantitated using the BCA
assay (Pierce). COX-1 and COX-2 antibodies (Santa Cruz
Biotechnology Inc) were used in combination with
standard ECL techniques. Rabbit polyclonal IDO-specif-
ic antibody was generated against a C-terminal peptide
of 42 amino acids; KPSKKKPTDGDKSEEPSNVESRGT-
GGTNPMTELRSVKDTTEK.
Measurement of tryptophan depletion by HPLC
Supernatants from cell cultures were extracted with
HPLC grade methanol and analyzed on a Beckman Phe-
nomenix C18(2) HPLC column and eluted with a 0-80%
gradient of acetonitrile over 20 minutes. To validate re-
tention times and for the construction of a concentration
curve a standard mixture of kynurenine and tryptophan
was analyzed for each assay.
Analysis of prostaglandin production
Prostaglandin synthesis was measured by pulsing IDO-
expressing RAW cells and vector only controls with 14C
arachidonic acid (Sigma). 5 ×  106 cells were harvested
and resuspended in PBS and incubated at 37° C with 1.3
mCi arachidonic acid (53 mCi/mmol) for 30 mins. Fol-
lowing ether extraction, samples were dissolved in ethyl
acetate and spotted onto thin layer chromatography
plates. Plates were developed in ethyl acetate: acetic acid,
90:1, together with unlabeled standards. Individual
spots were excised from the chromatogram and radioac-
tivity determined by scintillation counting.
Cell adhesion assay
Cell adhesion assays were performed essentially as de-
scribed [36]. Briefly, cells were seeded into the wells of a
24 well plate coated with various growth substrates Fol-
lowing incubation at 37° C, for 45 minutes, cells unat-
tached cells were removed by PBS washes and the
remaining cells were counted.
Cell migration assay
P19 cells in log phase growth were trypsinized and 105
were seeded in quadruplicate into Falcon cell culture in-
serts, with or without Matrigel coating (Becton Dickin-
son, Franklin Lakes, NJ, 8.0 µ m pore size, 1 ×  105pores/
sq.cm), in a volume of 0.2 ml, in a 24 well tissue culture
plate. The lower chamber contained a volume of 0.8 ml
growth medium, while the final volume in the upper
chamber was 0.35 ml. Chambers were incubated for 18
hours after which time the number of cells in the lower
chamber was determined.
Image analysis
The size of individual P19 aggregates was determined by
capturing fields of 40-50 aggregates at 10x magnification
and then calculating the area of each aggregate using theBMC  Biochemistry  (2001)  2:5  http://www.biomedcentral.com/1471-2091/2/5
NIH Image (1.62) analysis program ( [http://rsb.in-
fo.nih.gov/nih-image/download.html] ).
Abbreviations
CMV: cytomegalovirus
COX: cyclooxygenase
IDO: indoleamine 2,3 dioxygenase
IFN-γ  interferon gamma
LPS: lipopolysaccharide
MMP: matrix metalloproteinase
NSAID: non-steroidal anti-inflammatory drug
PG: prostaglandin
TDO: tryptophan 2, 3 dioxygenase
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